1. Baek, J. H., Kim, J.-A. Kang, C. M., Lee, Y. S. and Kim, K.-W. Induction of apoptosis by bile acids in HepG2 human hepatocellular carcinoma cells.The Korean J. Physiol. & Pharmacol. In press.
2. Barone, M., Panella, C., Angeli, A., Romanelli, D. and Francavilla, A., Studiesin vitro on the influence of ursodeoxycholate sodium salt on hepatocyte proliferation.J. Surg. Oncol. Suppl., 3, 8–13 (1993).
3. Boucher, E., Jouanolle, H., Andre, P., Ruffault, A., Guyader, D., Moirand, R., Turlin, B., Jacquelinet, C., Brissot, P. and Deugnier, Y., Interferone and ursodeoxycholic acid combined therapy in the treatment of chronal viral C hepatitis: results from a controlled randomized trial in 80 patients.Hepatology, 21, 322–327 (1995).
4. Bouscarel, B., Fromm, H., Cerak, S. and Cassidy, M. M., Ursodeoxycholic acid increases low-density lipoprotein binding, uptake and degradation in isolated hamster hepatocytes.Biochem. J., 280, 589–598 (1991).
5. Burton, K., Determination of DNA concentration with diphenylamine.Methods Enzymol., 12B, pp. 163–169, 1968.